- Home
- VERU vs JLS Comparison
VERU vs JLS Comparison
Compare VERU & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- JLS
- Stock Information
- Founded
- VERU 1971
- JLS 2009
- Country
- VERU United States
- JLS United States
- Employees
- VERU N/A
- JLS N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- JLS Investment Managers
- Sector
- VERU Health Care
- JLS Finance
- Exchange
- VERU Nasdaq
- JLS Nasdaq
- Market Cap
- VERU 108.8M
- JLS 102.7M
- IPO Year
- VERU 1990
- JLS N/A
- Fundamental
- Price
- VERU $0.57
- JLS $18.87
- Analyst Decision
- VERU Strong Buy
- JLS
- Analyst Count
- VERU 4
- JLS 0
- Target Price
- VERU $4.00
- JLS N/A
- AVG Volume (30 Days)
- VERU 6.2M
- JLS 26.6K
- Earning Date
- VERU 02-13-2025
- JLS 01-01-0001
- Dividend Yield
- VERU N/A
- JLS 9.33%
- EPS Growth
- VERU N/A
- JLS N/A
- EPS
- VERU N/A
- JLS N/A
- Revenue
- VERU $16,886,419.00
- JLS N/A
- Revenue This Year
- VERU N/A
- JLS N/A
- Revenue Next Year
- VERU N/A
- JLS N/A
- P/E Ratio
- VERU N/A
- JLS N/A
- Revenue Growth
- VERU 22.46
- JLS N/A
- 52 Week Low
- VERU $0.49
- JLS $15.48
- 52 Week High
- VERU $1.92
- JLS $17.97
- Technical
- Relative Strength Index (RSI)
- VERU 44.48
- JLS 56.67
- Support Level
- VERU $0.49
- JLS $18.75
- Resistance Level
- VERU $0.56
- JLS $19.06
- Average True Range (ATR)
- VERU 0.05
- JLS 0.16
- MACD
- VERU 0.00
- JLS -0.02
- Stochastic Oscillator
- VERU 63.62
- JLS 61.40
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The Fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.